Wendy E. McDermott - 09 Feb 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
VP, Human Resources
Signature
/s/ Wendy E. McDermott
Issuer symbol
LXRX
Transactions as of
09 Feb 2023
Net transactions value
$0
Form type
4
Filing time
13 Feb 2023, 16:02:37 UTC
Previous filing
14 Feb 2022
Next filing
01 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Award $0 +83,090 $0.000000 83,090 09 Feb 2023 Common Stock 83,090 Direct F1, F2
transaction LXRX Stock Option (Right to Buy) Award $0 +249,280 $0.000000 249,280 09 Feb 2023 Common Stock 249,280 $2.43 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
F3 Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.